Haruvi Takes Charge Of Sandoz North America
Takes Over From Carol Lynch As Leader In US And Canada
Executive Summary
Novartis has appointed its former global head of M&A, Keren Haruvi, to take over from Carol Lynch as president of Sandoz US and head of North America.
You may also be interested in...
Sandoz Launches US Awareness Campaign
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
US Saves $313bn From Generics And $2.2bn From Biosimilars
The AAM’s 2019 report titled ‘Securing Our Access & Savings’ throws light on the monumental savings and benefits of generics and biosimilars for US patients and other stakeholders. The report urges policymakers to act to address obstacles to the off-patent industry and brings industry’s COVID-19 response in perspective again.
Sandoz And Aurobindo Cancel US Deal
Sandoz and Aurobindo have mutually agreed to terminate their billion-dollar agreement that would have seen the Indian company acquire Sandoz’ dermatology and oral solids businesses in the US, citing a delay in FTC approval for the deal.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: